bioavail of oral antibiot in cystic fibrosi the present investig wa design to assess the absorpt and disposit in cystic fibrosi patient of two commonli use antibiot an aminopenicillin epicillin and a cephalexin ospexin the pharmacokinet paramet of epicillin in patient with cf and their normal control differ in a number of aspect the differ found in the maxim plasma concentr could be account for by a manifold increas in the renal clearanc of the drug our data support the idea that patient with cf exhibit an unusu larg and rapid renal clearanc of certain penicillin